Retrieve available abstracts of 31 articles: HTML format
Single Articles
June 2025
HO MS Clearance Pathways for alpha-Synuclein in Parkinson's Disease.
J Neurochem. 2025;169:e70124. PubMedAbstract available
May 2025
JING Y, Zhu H, Yao P, Chen Y, et al IgD-CD38-B Cell Partially Mediates the Protective Effect of Higher Serum
Triacylglycerol (53:4) Levels Against Parkinson's Disease.
J Neurochem. 2025;169:e70067. PubMedAbstract available
April 2025
MUSTHAFA T, Nizami SK, Mishra A, Hasan G, et al Altered Mitochondrial Bioenergetics and Calcium Kinetics in Young-Onset PLA2G6
Parkinson's Disease iPSCs.
J Neurochem. 2025;169:e70059. PubMedAbstract available
March 2025
LI Y, Jiang J, Li J, Liu S, et al Exosome-Derived CDC42 From Hypoxia-Pretreated Neural Stem Cells Inhibits
ACSL4-Related Ferroptosis to Alleviate Vascular Injury in Parkinson's Disease
Mice Models.
J Neurochem. 2025;169:e70027. PubMedAbstract available
February 2025
PRATES-RODRIGUES M, Schweizer BLA, de Paula Gomes C, Ribeiro AM, et al Challenges and Opportunities in Exploring Non-Motor Symptoms in 6-Hydroxydopamine
Models of Parkinson's Disease: A Systematic Review.
J Neurochem. 2025;169:e70008. PubMedAbstract available
POKHAREL PV, Newchurch AM, Overby SC, Spease CA, et al Oxidative Stress Suppresses Trk Signaling While Stimulating JNK-Mediated
Endocytosis and Cleavage of p75(NTR): A Targetable Pathway for Neuroprotection in
a Parkinson's Disease Model.
J Neurochem. 2025;169:e70010. PubMedAbstract available
PICCOLI M, Barbato L, Maiorana NV, Mingione A, et al Direct Current Stimulation (DCS) Modulates Lipid Metabolism and Intercellular
Vesicular Trafficking in SHSY-5Y Cell Line: Implications for Parkinson's Disease.
J Neurochem. 2025;169:e70014. PubMedAbstract available
November 2024
WITZIG V, Pjontek R, Tan SKH, Schulz JB, et al Modulating the cholinergic system-Novel targets for deep brain stimulation in
Parkinson's disease.
J Neurochem. 2024 Nov 18. doi: 10.1111/jnc.16264. PubMedAbstract available
October 2024
RETRACTION: The oxysterol 27-hydroxycholesterol regulates alpha-synuclein and
tyrosine hydroxylase expression levels in human neuroblastoma cells through
modulation of liver X receptors and estrogen receptors-relevance to Parkinson's
disease.
J Neurochem. 2024 Oct 15. doi: 10.1111/jnc.16240. PubMedAbstract available
September 2024
GOLDSTEIN DS, Sullivan P, Holmes C Cerebrospinal fluid concentration gradients of catechols in synucleinopathies.
J Neurochem. 2024;168:2926-2934. PubMedAbstract available
ONAL G, Yalcin-Cakmakli G, Ozcelik CE, Boussaad I, et al Variant-specific effects of GBA1 mutations on dopaminergic neuron proteostasis.
J Neurochem. 2024;168:2543-2560. PubMedAbstract available
June 2024
ALVES BDS, Schimith LE, da Cunha AB, Dora CL, et al Omega-3 polyunsaturated fatty acids and Parkinson's disease: A systematic review
of animal studies.
J Neurochem. 2024 Jun 24. doi: 10.1111/jnc.16154. PubMedAbstract available
May 2024
LI J, Ng KW, Sung CC, Chung KKK, et al The role of age-associated alpha-synuclein aggregation in a conditional
transgenic mouse model of Parkinson's disease: Implications for Lewy body
formation.
J Neurochem. 2024 May 1. doi: 10.1111/jnc.16122. PubMedAbstract available
March 2024
NETZAHUALCOYOTZI C, Santillan-Cigales JJ, Adalid-Peralta LV, Velasco I, et al Infiltration of immune cells to the brain and its relation to the pathogenesis of
Alzheimer's and Parkinson's diseases.
J Neurochem. 2024 Mar 29. doi: 10.1111/jnc.16106. PubMedAbstract available
PLACIDO E, Koss DJ, Outeiro TF, Brocardo PS, et al Altered hippocampal doublecortin expression in Parkinson's disease.
J Neurochem. 2024 Mar 14. doi: 10.1111/jnc.16101. PubMedAbstract available
KALINICHENKO LS, Kohl Z, Muhle C, Hassan Z, et al Sex-specific pleiotropic changes in emotional behavior and alcohol consumption in
human alpha-synuclein A53T transgenic mice during early adulthood.
J Neurochem. 2024;168:269-287. PubMedAbstract available
January 2024
CARMONA A, Carboni E, Gomes LC, Roudeau S, et al Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease
or multiple sclerosis.
J Neurochem. 2024 Jan 5. doi: 10.1111/jnc.16040. PubMedAbstract available
December 2023
ZHANG F, Yang D, Li J, Du C, et al Synaptotagmin-11 regulates immune functions of microglia in vivo.
J Neurochem. 2023;167:680-695. PubMedAbstract available
RENTSCH P, Egan T, Kuriakose A, Stayte S, et al The ratio of M1 to M2 microglia in the striatum determines the severity of
L-Dopa-induced dyskinesias.
J Neurochem. 2023;167:633-647. PubMedAbstract available
November 2023
BILLINGS JL, Hilton JBW, Liddell JR, Hare DJ, et al Fundamental Neurochemistry Review: Copper availability as a potential therapeutic
target in progressive supranuclear palsy: Insight from other neurodegenerative
diseases.
J Neurochem. 2023;167:337-346. PubMedAbstract available
SONG DY, Yuan L, Cui N, Feng C, et al alpha-Synuclein induces deficiency in clathrin-mediated endocytosis through
inhibiting synaptojanin1 expression.
J Neurochem. 2023;167:461-484. PubMedAbstract available
September 2023
WANG J, Joseph S, Vingill S, Dere E, et al Loss of the parkinsonism-associated protein FBXO7 in glutamatergic forebrain
neurons in mice leads to abnormal motor behavior and synaptic defects.
J Neurochem. 2023 Sep 27. doi: 10.1111/jnc.15962. PubMedAbstract available
MUHAMMAD B, Li H, Gu Y, Xue S, et al IL-1beta/IL-1R1 signaling is involved in the propagation of alpha-synuclein pathology of
the gastrointestinal tract to the brain.
J Neurochem. 2023;166:830-846. PubMedAbstract available
CHENG JY, Deng YT, Yu JT The causal role of circulating amino acids on neurodegenerative disorders: A
two-sample Mendelian randomization study.
J Neurochem. 2023;166:972-981. PubMedAbstract available
July 2023
WARTH PEREZ ARIAS CC, Silbern I, Caldi Gomes L, Wartmann H, et al Proteomic analysis of the human hippocampus identifies neuronal pentraxin 1
(NPTX1) as synapto-axonal target in late-stage Parkinson's disease.
J Neurochem. 2023 Jul 28. doi: 10.1111/jnc.15924. PubMedAbstract available
June 2023
GASPAROTTO J, Somensi N, Girardi CS, Bittencourt RR, et al Is it all the RAGE? Defining the role of the receptor for advanced glycation end
products in Parkinson's disease.
J Neurochem. 2023 Jun 28. doi: 10.1111/jnc.15890. PubMedAbstract available
HE H, Zhang Q, Liao J, Lei J, et al METTL14 is decreased and regulates m(6) A modification of alpha-synuclein in
Parkinson's disease.
J Neurochem. 2023 Jun 13. doi: 10.1111/jnc.15882. PubMedAbstract available
BARINGER SL, Simpson IA, Connor JR Brain iron acquisition: An overview of homeostatic regulation and disease
dysregulation.
J Neurochem. 2023;165:625-642. PubMedAbstract available
April 2023
MASUKAWA D, Kitamura S, Tajika R, Uchimura H, et al Coupling between GPR143 and dopamine D2 receptor is required for selective
potentiation of dopamine D2 receptor function by L-3,4-dihydroxyphenylalanine in
the dorsal striatum.
J Neurochem. 2023;165:177-195. PubMedAbstract available
BRONTESI L, Imberdis T, Ramalingam N, Dettmer U, et al The effects of KTKEGV repeat motif and intervening ATVA sequence on alpha-synuclein
solubility and assembly.
J Neurochem. 2023;165:246-258. PubMedAbstract available
February 2023
CHEN YH, Kuo YY, You YQ, Lin YT, et al Endonuclease VIII-like 1 deficiency potentiates nigrostriatal dopaminergic neuron
degeneration in a male mouse model of Parkinson's disease.
J Neurochem. 2023 Feb 24. doi: 10.1111/jnc.15794. PubMedAbstract available